COMMUNIQUÉS West-GlobeNewswire

-
CervoMed to Present New Data from Phase 2b RewinD-LB Study at AAIC 2025 and Host Conference Call on July 28, 2025
24/07/2025 -
RxSight, Inc. to Report Second Quarter 2025 Financial Results on August 7, 2025
24/07/2025 -
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2025 Financial Results on August 7, 2025
24/07/2025 -
Pharvaris Announces Closing of $201.2 Million Upsized Public Offering of Ordinary Shares and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares
24/07/2025 -
The Ensign Group Reports Second Quarter 2025 Results; Raises Annual Earnings and Revenue Guidance
24/07/2025 -
HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results
24/07/2025 -
CooperCompanies Announces Release Date for Third Quarter 2025
24/07/2025 -
Rakovina Therapeutics Announces Warrant Exercise Incentive Program
24/07/2025 -
Profound Medical to Release Second Quarter 2025 Financial Results on August 14 – Conference Call to Follow
24/07/2025 -
Algernon Announces Closing of the Private Placement Financing
24/07/2025 -
Scienture Holdings, Inc. Obtains $1.2 Million in Bridge Funding
24/07/2025 -
Natural Brain Support Without the Crash: Lives Potions Introduces Plant-Based Cognitive Enhancement
24/07/2025 -
Guerbet : Chiffre d’affaires du 1er semestre 2025
24/07/2025 -
Guerbet : H1 2025 revenue
24/07/2025 -
Omniscient and The Jacobs Institute, Inc. Announce Strategic Partnership to Pioneer Clinical Connectomics
24/07/2025 -
Fairhaven Health Strengthens Women’s Health Commitment Beyond Fertility
24/07/2025 -
Approbation de Cabometyx® dans l’UE pour les tumeurs neuroendocrines avancées précédemment traitées
24/07/2025 -
Cabometyx® approved in the EU for previously treated advanced neuroendocrine tumors
24/07/2025 -
Merakris Therapeutics Spotlights Investigational New Drug, MTX-001, with Innovation Showcase Win at 2025 Advanced Wound Care Summit
24/07/2025
Pages